Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanxiao Chen

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Cancer Letters|October 23, 2018
Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancerZhijie Wang, Shuai Fu, Jun Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Treatment Efficacy, Chemoradiotherapy Benefits, and Survival Disparities by Histology in Primary Mediastinal Germ Cell Tumors: 15-Year Results of a Single-Center Cohort StudyDi Wu, Ziran Zhang, Jun Nie, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Survival difference between <i>EGFR</i> Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysisMinglei Zhuo, Qiwen Zheng, Jun Zhao, et al.
BMC Cancer|July 19, 2020
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) databaseBo Jia, Qiwen Zheng, Jingjing Wang, et al.
Annals of Translational Medicine|February 8, 2021
Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patientsYida Wang, Hanxiao Chen, Tianzhuo Zhang, et al.
Thoracic Cancer|January 11, 2018
Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinomaJia Zhong, Qiwen Zheng, Emei Gao, et al.
Journal of Thoracic Disease|April 12, 2021
Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I-IIIA non-small cell lung cancer patientsBo Jia, Qiwen Zheng, Jianjie Li, et al.
Thoracic Cancer|July 31, 2018
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancerChunxin Lv, Xiuju Liu, Qiwen Zheng, et al.
BMC Cancer|August 26, 2020
Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysisJianjie Li, Qiwen Zheng, Xinghui Zhao, et al.
Research (Washington, D.C.)|October 14, 2024
Erratum to "Enhanced Effects of Intermittent Fasting by Magnetic Fields in Severe Diabetes"Ying Wang, Chuanlin Feng, Biao Yu, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Cancer Letters|October 23, 2018
Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancerZhijie Wang, Shuai Fu, Jun Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Treatment Efficacy, Chemoradiotherapy Benefits, and Survival Disparities by Histology in Primary Mediastinal Germ Cell Tumors: 15-Year Results of a Single-Center Cohort StudyDi Wu, Ziran Zhang, Jun Nie, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Survival difference between <i>EGFR</i> Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysisMinglei Zhuo, Qiwen Zheng, Jun Zhao, et al.
BMC Cancer|July 19, 2020
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) databaseBo Jia, Qiwen Zheng, Jingjing Wang, et al.
Annals of Translational Medicine|February 8, 2021
Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patientsYida Wang, Hanxiao Chen, Tianzhuo Zhang, et al.
Thoracic Cancer|January 11, 2018
Influence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinomaJia Zhong, Qiwen Zheng, Emei Gao, et al.
Journal of Thoracic Disease|April 12, 2021
Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I-IIIA non-small cell lung cancer patientsBo Jia, Qiwen Zheng, Jianjie Li, et al.
Thoracic Cancer|July 31, 2018
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancerChunxin Lv, Xiuju Liu, Qiwen Zheng, et al.
BMC Cancer|August 26, 2020
Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysisJianjie Li, Qiwen Zheng, Xinghui Zhao, et al.
Research (Washington, D.C.)|October 14, 2024
Erratum to "Enhanced Effects of Intermittent Fasting by Magnetic Fields in Severe Diabetes"Ying Wang, Chuanlin Feng, Biao Yu, et al.
Pageof 10